Bausch Health’s Sal­ix spot­lights liv­er dis­ease in­di­ca­tion for Xi­fax­an

Most peo­ple know Bausch Health’s Sal­ix drug Xi­fax­an for its ir­ri­ta­ble bow­el syn­drome in­di­ca­tion, thanks to con­sumer mar­ket­ing ef­forts. But now Sal­ix is re­mind­ing peo­ple …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER